Skip to content

Texas Oncologist Sues Drug Counterfeiter for Selling Him Fake Drugs

Dr. Mohamad Ayman Ghraowi has filed suit against Canada Drugs subsidiaries Montana Healthcare Solutions and Rockeley Ventures, for supplying his practice with counterfeit cancer medication, the Courthouse News Service (CNS) reports.

Dr. Mohamad Ayman Ghraowi has filed suit against Canada Drugs subsidiaries Montana Healthcare Solutions and Rockeley Ventures, for supplying his practice with counterfeit cancer medication, the Courthouse News Service (CNS) reports.

Dr. Ghraowi’s South Texas Comprehensive Cancer Centers once offered service at five different clinics in and around Corpus Christi, Texas, but now all are shuttered after paying a $900,000 fine to the Food and Drug Administration (FDA).

In April 2015, according to the FDA, Dr. Ghraowi’s South Texas Cancer Centers settled with the FDA on charges that they caused “the introduction into interstate commerce of misbranded prescription cancer drugs worth more than $900,000, between Feb. 22, 2010, and Jan. 17, 2012. STCCC was a professional association existing under Texas state law with clinics located within the Southern District of Texas, which provided care and treatment for patients with cancer and blood diseases.”

According to the CNS, Dr. Ghraowi insists that Montana Healthcare Solutions salesman Paul Bottomley assured him that the oncology drugs he was purchasing were FDA approved. As the result of the fines he has paid, Dr. Ghraowi has had to close all of his clinics and sell off all his business equipment to cover his debts. CNS goes on to report that “Ghraowi wants the defendants held liable for the $900,000 fine, lost wages and treble damages for RICO Act violations.”

By S. Imber

Scroll To Top